Positioning promising biomedical technologies to address UNDER SERVED healthcare needs

The Columbia-Coulter Translational Research Partnership promotes, develops, and supports innovations to improve patient care. The program provides mentoring, project management, and funding to promising translational projects with the goal of moving innovative technologies to clinical application through commercialization. The ultimate goal is to develop health care solutions that address unmet or underserved clinical needs and lead to improvements in patient care.

Eligible teams must include an engineer, preferably from Columbia's Fu Foundation School of Engineering and Applied Science with an affiliation to the Department of Biomedical Engineering, and a practicing clinician, preferably with an appointment at Columbia University Medical Center. All members of the team should be committed to commercialization objectives and be open to receiving mentorship, coaching, and oversight of their projects. See Eligibility to find out more on who can apply. 

Through the Partnership, selected teams receive funding and guidance to advance nascent ideas from conception to proof-of-concept. The program aims to better position these ideas for partnering with a commercial entity that will invest the necessary resources to bring the concept to market. Successful proposals must be translational in nature, i.e. they must focus on efforts to translate research results into practical clinical application.


Over $700,000 of funding is available to support selected projects, with an additional $300,000 worth of in-kind additional resources (marketing, regulatory, reimbursement, and legal). 


Selected teams are connected with experts in regulatory strategy, intellectual property counsel, reimbursement, marketing identifying and product development.


Funded project teams work with a commercialization team as active partners, and meet regularly with Program Management to review technical and business milestones.